Abstract
BackgroundNeurological and psychiatric disorders are serious and expensive global public health problems. Therefore, exploring effective intervention technologies plays an important role in improving patients’ clinical symptoms and social functions, as well as reducing medical burden.ObjectiveThe aim of this study is to analyze and summarize the key new technologies and innovative development trends witnessed globally for neurological illness and psychiatric disorders by mining the relevant patent data.MethodsA bibliometric analysis was conducted on patent applications, priority countries, main patentees, hot technologies, and other patent information on neurological and psychiatric disorders, revealing the current situation along with the trend of technology development in this field.ResultsIn recent years, inventions and innovations related to neurological and psychiatric diseases have become very active, with China being the largest patent priority country. Of the top patent holders, Visicu (headquartered in the United States) is the leader. The distribution of patent holders in China remains relatively scattered, with no monopoly organization at present. Global technologies on neurological illness and psychiatric disorders are mainly concentrated around A61B (diagnosis, surgery, and identification).ConclusionsThis paper analyzed and summarized the key new technologies and global innovative development trends of neurological and psychiatric diseases by mining the relevant patent data, and provides practical references and research perspectives for the prevention and treatment of the aforesaid diseases.
Highlights
Neurological diseases mainly include diseases of the central nervous system, peripheral nervous system, skeletal muscle, among others, whereas mental diseases pertain to obstacles in mental development, emotion, volition, and behavior, etc
A total of 328 patents related to neurological and psychiatric diseases were retrieved from 16 countries, including 191 applications for inventions, 104 grants for inventions, designs, and utility models
Trend analysis was performed on the number of patent applications submitted annually (Figure 1)
Summary
Neurological diseases mainly include diseases of the central nervous system, peripheral nervous system, skeletal muscle, among others, whereas mental diseases pertain to obstacles in mental development, emotion, volition, and behavior, etc. Japan, Australia, and other developed countries have commenced long-term projects and increased financial support for scientific studies on neurological illness and psychiatric disorders [1,2,3] by proposing special and strategic plans to constantly expand research (both studies and teams) in this area. As for China, financial support for studies on neurological and psychiatric diseases mainly comes from the National Natural Science Foundation (NSFC), the National Key Research and Development Plan, the National Key Basic Research and Development Plan of the Ministry of Science and Technology (973 Plan), and the National High-tech Research and Development Plan (863 Plan). Chinese studies were mainly performed on basic neurobiology techniques, neuropsychiatric diseases, brainlike artificial intelligence, transformative neuroscience, and supporting platform construction. Exploring effective intervention technologies plays an important role in improving patients’ clinical symptoms and social functions, as well as reducing medical burden
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
